Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01753830 · ClinicalTrials.gov registry record · NA

Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis

A NA study, sponsored by Galderma R&D.

Terminated
Registry status
NA
Development phase
75
Enrollment target

NCT01753830: Clinical Trial NA study, sponsored by Galderma R&D.

NCT01753830 is a NA study that was terminated before completion, run by Galderma R&D. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01753830, a NA study, was terminated before completion, sponsored by Galderma R&D.

TERMINATED
Registry status
NA
Development phase
75 participants
Enrollment target

Study Summary

The purpose of the study is to determine whether a single intra-articular injection of Durolane 4.5 mL is superior to a single injection of PBS 4.5 mL for the relief of joint pain in patients with osteoarthritis of the knee.

Primary Outcome

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain score (0-100 mm Visual Analogue Scale (VAS)). Lower score mean less pain.

Interventions

  • DEVICE PBS
  • DEVICE Durolane

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2012-12
Est. Completion 2014-02
Phase NA
Galderma R&D

158 total trials

Why NCT01753830 stopped before completion

NCT01753830 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which PBS is the first listed.

NCT01753830 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01753830 about?

NCT01753830 is a clinical study titled "Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis". The purpose of the study is to determine whether a single intra-articular injection of Durolane 4.5 mL is superior to a single injection of PBS 4.5 mL for the relief of joint pain in patients with osteoarthritis of the knee.

What is the current status of trial NCT01753830?

This trial is currently terminated. It is a NA study. The enrollment target is 75 participants. The study started on 2012-12. Estimated completion is 2014-02.

What interventions are being tested in trial NCT01753830?

The interventions under investigation include: PBS (DEVICE), Durolane (DEVICE).

Who is sponsoring clinical trial NCT01753830?

This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01753830's enrollment target sits among peer trials

75 1069th of 2000 higher than 919 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01753830, the US trial registry maintained by the National Library of Medicine. NCT01753830 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.